Published in Cell Transplant on January 01, 2004
Effects of Hyperoxia on Oxygen-Related Inflammation with a Focus on Obesity. Oxid Med Cell Longev (2015) 0.79
Postnatal hyperoxia exposure differentially affects hepatocytes and liver haemopoietic cells in newborn rats. PLoS One (2014) 0.78
Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy. N Engl J Med (2011) 6.34
Stem-cell-based, tissue engineered tracheal replacement in a child: a 2-year follow-up study. Lancet (2012) 4.54
Is maximum conservative management an equivalent treatment option to dialysis for elderly patients with significant comorbid disease? Clin J Am Soc Nephrol (2009) 2.62
Ischemia-reperfusion injury of the intestine and protective strategies against injury. Dig Dis Sci (2004) 2.54
Nanosilver as a new generation of nanoproduct in biomedical applications. Trends Biotechnol (2010) 2.41
Biological applications of quantum dots. Biomaterials (2007) 2.22
The contemporary role of antioxidant therapy in attenuating liver ischemia-reperfusion injury: a review. Liver Transpl (2005) 2.04
Properties of the amniotic membrane for potential use in tissue engineering. Eur Cell Mater (2008) 2.01
Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer. Trends Pharmacol Sci (2009) 1.98
Remote ischemic preconditioning: a novel protective method from ischemia reperfusion injury--a review. J Surg Res (2008) 1.81
Inflammatory stress exacerbates lipid accumulation in hepatic cells and fatty livers of apolipoprotein E knockout mice. Hepatology (2008) 1.77
The roles of tissue engineering and vascularisation in the development of micro-vascular networks: a review. Biomaterials (2005) 1.75
EPA and DHA reduce LPS-induced inflammation responses in HK-2 cells: evidence for a PPAR-gamma-dependent mechanism. Kidney Int (2005) 1.64
ANCA +ve vasculitis after autologous PBSC transplantation. Nephrol Dial Transplant (2002) 1.61
Silsesquioxane nanocomposites as tissue implants. Plast Reconstr Surg (2007) 1.56
Current status of prosthetic bypass grafts: a review. J Biomed Mater Res B Appl Biomater (2005) 1.56
Endometrial stem cell differentiation into smooth muscle cell: a novel approach for bladder tissue engineering in women. BJU Int (2013) 1.46
Polymeric heart valves: new materials, emerging hopes. Trends Biotechnol (2009) 1.41
Polyhedral oligomeric silsesquioxane nanocomposites: the next generation material for biomedical applications. Acc Chem Res (2005) 1.31
The role of the insulin-like growth factor system in colorectal cancer: review of current knowledge. Int J Colorectal Dis (2005) 1.30
Biomaterials and scaffold design: key to tissue-engineering cartilage. Biotechnol Appl Biochem (2007) 1.27
Biofunctionalization of biomaterials for accelerated in situ endothelialization: a review. Biomacromolecules (2008) 1.27
Protocols and mechanisms for remote ischemic preconditioning: a novel method for reducing ischemia reperfusion injury. Transplantation (2007) 1.22
Protection of the liver by ischemic preconditioning: a review of mechanisms and clinical applications. Dig Surg (2003) 1.21
A new era of cancer treatment: carbon nanotubes as drug delivery tools. Int J Nanomedicine (2011) 1.20
The application of exosomes as a nanoscale cancer vaccine. Int J Nanomedicine (2010) 1.18
Mechanisms of dysregulation of low-density lipoprotein receptor expression in vascular smooth muscle cells by inflammatory cytokines. Arterioscler Thromb Vasc Biol (2006) 1.16
Biology of insulin-like growth factor binding protein-4 and its role in cancer (review). Int J Oncol (2006) 1.16
Anti-atherosclerotic effects of sirolimus on human vascular smooth muscle cells. Am J Physiol Heart Circ Physiol (2007) 1.13
Advancing cartilage tissue engineering: the application of stem cell technology. Curr Opin Biotechnol (2005) 1.13
Clinical potential of quantum dots. J Biomed Biotechnol (2007) 1.12
Vascular risk factors in South Asians. Int J Cardiol (2008) 1.11
In situ endothelialization potential of a biofunctionalised nanocomposite biomaterial-based small diameter bypass graft. Biomed Mater Eng (2009) 1.10
Impairment of hepatic microcirculation in fatty liver. Microcirculation (2003) 1.10
Exosomes as nano-theranostic delivery platforms for gene therapy. Adv Drug Deliv Rev (2012) 1.10
PPAR agonists protect mesangial cells from interleukin 1beta-induced intracellular lipid accumulation by activating the ABCA1 cholesterol efflux pathway. J Am Soc Nephrol (2003) 1.10
Apoptosis and colorectal cancer: implications for therapy. Trends Mol Med (2009) 1.09
Modern surgical management of peripheral nerve gap. J Plast Reconstr Aesthet Surg (2010) 1.09
Cardiovascular application of polyhedral oligomeric silsesquioxane nanomaterials: a glimpse into prospective horizons. Int J Nanomedicine (2011) 1.09
Stem cells and cancer: an overview. Stem Cell Rev (2007) 1.07
Toxicology and clinical potential of nanoparticles. Nano Today (2011) 1.05
Nerve conduits for peripheral nerve surgery. Plast Reconstr Surg (2014) 1.04
Immunomodulatory effect of a decellularized skeletal muscle scaffold in a discordant xenotransplantation model. Proc Natl Acad Sci U S A (2013) 1.03
Tissue engineering of small intestine--current status. Biomacromolecules (2006) 1.01
Effect of graduated compression stockings on limb oxygenation and venous function during exercise in patients with venous insufficiency. Vascular (2004) 1.01
Functionalization of single-walled carbon nanotubes and their binding to cancer cells. Int J Nanomedicine (2012) 1.00
Fluorescence nanoparticles "quantum dots" as drug delivery system and their toxicity: a review. J Drug Target (2010) 0.99
Achieving the ideal properties for vascular bypass grafts using a tissue engineered approach: a review. Med Biol Eng Comput (2007) 0.98
The relationship of hepatic tissue oxygenation with nitric oxide metabolism in ischemic preconditioning of the liver. FASEB J (2002) 0.97
Effect of remote ischemic preconditioning on hepatic microcirculation and function in a rat model of hepatic ischemia reperfusion injury. HPB (Oxford) (2009) 0.97
The antithrombogenic potential of a polyhedral oligomeric silsesquioxane (POSS) nanocomposite. Biomacromolecules (2006) 0.97
Small calibre polyhedral oligomeric silsesquioxane nanocomposite cardiovascular grafts: influence of porosity on the structure, haemocompatibility and mechanical properties. Acta Biomater (2011) 0.96
The degradative resistance of polyhedral oligomeric silsesquioxane nanocore integrated polyurethanes: an in vitro study. Biomaterials (2005) 0.96
The use of animal models in developing the discipline of cardiovascular tissue engineering: a review. Biomaterials (2004) 0.96
A review of the carotid and femoral intima-media thickness as an indicator of the presence of peripheral vascular disease and cardiovascular risk factors. Cardiovasc Res (2002) 0.95
Nitric oxide: a guardian for vascular grafts? Chem Rev (2011) 0.95
Quantitating therapeutic disruption of tumor blood flow with intravital video microscopy. Cancer Res (2006) 0.95
Intima-media thickness of elastic and muscular arteries of young women with polycystic ovaries. Atherosclerosis (2004) 0.95
A nanocage for nanomedicine: polyhedral oligomeric silsesquioxane (POSS). Macromol Rapid Commun (2011) 0.95
Tissue engineering: revolution and challenge in auricular cartilage reconstruction. Plast Reconstr Surg (2012) 0.94
Manufacturing and hydrodynamic assessment of a novel aortic valve made of a new nanocomposite polymer. J Biomech (2012) 0.94
The endothelialization of polyhedral oligomeric silsesquioxane nanocomposites: an in vitro study. Cell Biochem Biophys (2006) 0.93
In vitro small intestinal epithelial cell growth on a nanocomposite polycaprolactone scaffold. Biotechnol Appl Biochem (2009) 0.93
Development of a hybrid cardiovascular graft using a tissue engineering approach. FASEB J (2002) 0.93
Advancing vascular tissue engineering: the role of stem cell technology. Trends Biotechnol (2005) 0.93
Skin regeneration scaffolds: a multimodal bottom-up approach. Trends Biotechnol (2012) 0.92
Effect of remote ischemic preconditioning on liver ischemia/reperfusion injury using a new mouse model. Liver Transpl (2011) 0.92
Anticoagulant and antiplatelet agents: their clinical and device application(s) together with usages to engineer surfaces. Biomacromolecules (2004) 0.92
Inflammatory stress induces statin resistance by disrupting 3-hydroxy-3-methylglutaryl-CoA reductase feedback regulation. Arterioscler Thromb Vasc Biol (2013) 0.91
Sirolimus inhibits endogenous cholesterol synthesis induced by inflammatory stress in human vascular smooth muscle cells. Am J Physiol Heart Circ Physiol (2010) 0.91
Ischemic preconditioning of small bowel mitigates the late phase of reperfusion injury: heme oxygenase mediates cytoprotection. Am J Surg (2009) 0.91
Addressing thrombogenicity in vascular graft construction. J Biomed Mater Res B Appl Biomater (2007) 0.91
A new biodegradable nanocomposite based on polyhedral oligomeric silsesquioxane nanocages: cytocompatibility and investigation into electrohydrodynamic jet fabrication techniques for tissue-engineered scaffolds. Biotechnol Appl Biochem (2009) 0.91
Interactions between endothelial cells and a poly(carbonate-silsesquioxane-bridge-urea)urethane. Biomaterials (2005) 0.91
Tissue-engineered heart valve: future of cardiac surgery. World J Surg (2012) 0.90
Nitric oxide synthase distribution and expression with ischemic preconditioning of the rat liver. FASEB J (2005) 0.90
Insulin-like growth factor binding protein-4 gene therapy increases apoptosis by altering Bcl-2 and Bax proteins and decreases angiogenesis in colorectal cancer. Int J Oncol (2007) 0.90
Polyhedral oligomeric silsequioxane-polyurethane nanocomposite microvessels for an artificial capillary bed. Biomaterials (2006) 0.90
Role of prosthetic conduits in coronary artery bypass grafting. Eur J Cardiothorac Surg (2011) 0.90
Time course and quantification of pancreatic islet revascularization following intraportal transplantation. Cell Transplant (2007) 0.90
Elevated concentrations of retinol-binding protein-4 (RBP-4) in gestational diabetes mellitus: negative correlation with soluble vascular cell adhesion molecule-1 (sVCAM-1). Gynecol Endocrinol (2008) 0.89
Optical techniques in the assessment of peripheral arterial disease. Curr Vasc Pharmacol (2007) 0.89
Gold revolution--gold nanoparticles for modern medicine and surgery. J Nanosci Nanotechnol (2011) 0.89
Optimization of chondrocyte isolation and characterization for large-scale cartilage tissue engineering. J Surg Res (2012) 0.89
Effect of ischemic preconditioning on hepatic microcirculation and function in a rat model of ischemia reperfusion injury. Liver Transpl (2002) 0.89
Chronic inflammation exacerbates glucose metabolism disorders in C57BL/6J mice fed with high-fat diet. J Endocrinol (2013) 0.89
A novel nanocomposite polymer for development of synthetic heart valve leaflets. Acta Biomater (2009) 0.88
Inflammatory stress exacerbates lipid-mediated renal injury in ApoE/CD36/SRA triple knockout mice. Am J Physiol Renal Physiol (2011) 0.88
Modulation of microcirculatory changes in the late phase of hepatic ischaemia-reperfusion injury by remote ischaemic preconditioning. HPB (Oxford) (2011) 0.88
Impaired carotid and femoral viscoelastic properties and elevated intima-media thickness in peripheral vascular disease. Atherosclerosis (2002) 0.88
Glycine maintains mitochondrial activity and bile composition following warm liver ischemia-reperfusion injury. J Gastroenterol Hepatol (2011) 0.88
Conjugation of quantum dots on carbon nanotubes for medical diagnosis and treatment. Int J Nanomedicine (2013) 0.88